News
J&J's Spravato gets another lift with new FDA approval
Johnson & Johnson's Spravato has become the first standalone drug to be cleared by the FDA for adults with treatment-resistant depression.
News
Trump pulls Biden policies on health insurance, drug pricing
President Trump has started dismantling health legislation introduced under the Biden administration on day one of his new term.
News
EU approves endometrial, lung cancer drugs from GSK and J&J
Both GSK and J&J have claimed pivotal approvals for growth-phase oncology therapies in the EU.
News
Could OTC Cialis for erectile dysfunction reach the US?
Sanofi's consumer healthcare unit Opella could finally be able to bring an OTC PDE-5 inhibitor for erectile dysfunction to the US market.
Sales & Marketing
The AI edge: Redefining commercial excellence in 2025
Biopharma companies are increasingly turning to artificial intelligence (AI) to enhance customer-focused commercial strategies, driving more tailored engagement and improved operational eff
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
